The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Share News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Tintra receives bid approach; NCC trading in line

Thu, 07th Sep 2023 20:27

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Amur Minerals Corp - Russia-focused nickel copper sulphide exploration company - Confirms that trading in the company's shares on AIM will be suspended with effect from today. Following the disposal of the AO Kun-Manie subsidiary, Amur became classified as an AIM Rule 15 cash shell and was required to make an acquisition or acquisitions which would constitute a reverse takeover under Rule 14 of the AIM rules for companies, or be re-admitted on AIM as an investing company under AIM rules on or before the date falling six months from March 6. As neither of these events have taken place, shares have been suspended. If no transaction has taken place in a further six months, trading in the shares will be cancelled.

----------

NCC Group PLC - Manchester-based cybersecurity company - Expects to report adjusted earnings before interest and tax in line with the outturn outlined in June's trading update. Current trading is in line with expectations with cost efficiencies across Cyber Security and corporate functions already being realised. In financial year 2024, expects to make modest improvement in adjusted Ebit driven by both the Cyber Security and Software Resilience businesses. Execution of the next chapter of the strategy is progressing well, with its global delivery and operations centre in Manila opening by the end of September 2023. Says results will now be released on September 27, and not September 14 as previously advised as the auditor has requested more time to complete all procedures.

----------

Vela Technologies PLC - early stage-focused technology investor - Further to announcement on August 15, notes that Murphy Canyon Acquisition Corp has recently announced that the special meeting of stockholders to approve its initial business combination with Conduit Pharmaceuticals Ltd has been postponed and will now be held on September 13. The meeting will also discuss Murphy's planned acquisition of an economic interest in AZD1656 from Vela for GBP4.0 million. Vela paid GBP2.4 million for an 8% economic interest in this asset in October 2020, which Murphy aims to buy for GBP4.0 million.

----------

Triple Point Social Housing REIT - London-based real estate investment trust - Reports EPRA net tangible assets per share of 111.31 pence at June 30, little changed from 111.80p the year before. Adjusted earnings per share fell to 2.21p from 2.57p. Dividend was unchanged at 2.73p.

----------

Renalytix PLC - London-based kidney health-focused diagnostics company - Appoints Howard Doran as chief business officer from September 1. His primary responsibility will be leading the KidneyIntelX global sales effort.

----------

Helium One Global Ltd - helium explorer in Tanzania - Raises GBP6.3 million from placing, subscription at 6 pence per share. Further, raises GBP0.5 million by a retail offer taking total proceeds of fundraise to GBP6.8 million.

----------

Restore PLC - London-based provider of digital and information management and lifecycle services - Jamie Hopkins, executive director, buys 47,350 shares at an average price of 210.1 pence worth GBP99,482.35. Following this transaction Hopkins holds 54,756 shares.

----------

Lexington Gold Ltd - gold exploration and development company with projects in the US states of North and South Carolina - Completes the acquisition of White Rivers Exploration Proprietary Ltd, an exploration and development company with significant gold assets in South Africa. Lexington Gold is now the sole ultimate beneficial owner of WRE with a 26% interest to be issued to Lexington Gold's partners in due course which will serve to reduce firm's resultant interest in WRE to 76%. In talks with a well-known group in South Africa and will announce further details when this transfer of ownership has been completed. As part of acquisition, issues 36.1 million new shares to rise GBP2.24 million, representing 35% of the maximum Lexington Gold equity of up to GBP6.4 million to be paid as consideration under the WRE acquisition and loan agreements.

----------

Seed Innovations Ltd - Guernsey-based wellness and life sciences company - Notes release by its portfolio company, Little Green Pharma Ltd. Results of study show medicinal cannabis significantly improves pain, quality of life & fatigue. Study was of 2,327 Australian patients.

----------

Yourgene Health PLC - Manchester, England-based molecular diagnostics group - Says at court sanction hearing today the court issued the court order sanctioning the scheme which facilitates the takeover by Novacyt SA. Confirms today will be last day of trading in Yourgene shares with trading suspended from September 8.

----------

Tintra PLC - builder of banking and infrastructure technology systems - Agrees in principle a possible cash offer by LRB 35 Ltd, an unquoted special purpose vehicle, currently controlled by its directors, Tariq Al Abdulla and Andrew Bascombe, but with backing from other existing non-management shareholders of Tintra, to acquire the company. Bid values each share in Tintra at 150 pence per share with a share exchange alternative. Board is minded to recommend the offer should a firm intention be made.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
8 Sep 2023 11:58

Novacyt completes buy of molecular diagnostics firm Yourgene Health

(Alliance News) - Yourgene Health PLC on Friday announced that its takeover by Novacyt SA, a biotechnology group focused on clinical diagnostics, is complete.

Read more
1 Sep 2023 21:59

Yourgene, Pathfinder, Spectral MD and Finncap to be deleted on AIM

(Alliance News) - FTSE Russell on Friday announced a number of deletion changes in the FTSE UK Index series.

Read more
17 Aug 2023 19:46

IN BRIEF: Novacyt takeover of Yourgene Health closer to completion

Yourgene Health PLC - Manchester, England-based molecular diagnostics group - Reports court-sanctioned scheme of arrangement to facilitate takeover by Novacyt SA has been approved by shareholders at a court and general meeting. Around 99% of shareholders who voted were in favour of the scheme. Takeover now requires the scheme of arrangement to be court sanctioned. These timings will be provided in due course.

Read more
10 Aug 2023 15:46

UK shareholder meetings calendar - next 7 days

Friday 11 August 
Crushmetric Group LtdAGM
SIMEC Atlantis Energy LtdAGM
TwentyFour Select Monthly Income Fund LtdAGM
Monday 14 August 
Ethernity Networks LtdAGM
Nanoco Group PLCGM re change in the control of the company
Tuesday 15 August 
Castings PLCAGM
Momentum Multi-Asset Value Trust PLCGM re reconstruction and voluntary winding-up
Primorus Investments PLCAGM
WH Ireland Group PLCGM re dealings in the new ordinary shares
Wednesday 16 August 
Cadence Minerals PLCAGM
Calnex Solutions PLCAGM
NextEnergy Solar Fund LtdAGM
NFT Investments PLCAGM
StreaksAI PLCAGM
VSA Capital Group PLCAGM
Thursday 17 August 
Harvest Minerals LtdAGM
Quantum Exponential Group PLCAGM
Windward LtdAGM
Yourgene Health PLCGM and court meeting re takeover by Novacyt
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
27 Jul 2023 16:30

TRADING UPDATES: Ithaca encouraged by K2; Safestyle profit warning

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
26 Jul 2023 12:44

IN BRIEF: Yourgene Health inks five-year, Illumina contract extension

Yourgene Health PLC - Manchester, England-based molecular diagnostics group - Signs five-year contract extension with Illumina Inc. The contract is a restated licence and supply agreement for Yourgene's sequencing based NIPT in vitro diagnostic products, which will now run until September 2028. Says the license allows it to continue its product development roadmaps, as it looks to further move into "key international markets, such as the Americas, UK, Europe and Australia.

Read more
3 Jul 2023 12:05

LONDON MARKET MIDDAY: Miners and oil majors lead FTSE 100 march

(Alliance News) - European equities went into Monday afternoon on the up, with the FTSE 100 outperforming as it was supported by its natural resources sector and oil majors.

Read more
3 Jul 2023 10:48

AIM WINNERS & LOSERS: Yourgene surges on takeover by Novacyt

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
3 Jul 2023 10:13

Yourgene Health agrees to GBP17 million acquisition offer from Novacyt

(Alliance News) - Yourgene Health PLC on Monday said it has agreed to a cash takeover offer from Novacyt SA that values Yourgene about GBP17 million.

Read more
3 Jul 2023 09:07

LONDON MARKET OPEN: Stocks start second half in green amid PMIs

(Alliance News) - European markets rose at Monday's open, kicking off the start of the second half on a positive note, boosted by strong trading in Asia and New York,

Read more
3 Jul 2023 09:07

Novacyt to buy Yourgene Health in £16.7m deal

(Sharecast News) - Yourgene Health surged on Monday after it agreed to be bought by Novacyt in a £16.7m deal.

Read more
13 Jun 2023 10:08

Yourgene Health shares rise on sale of Taiwan subsidiary

(Alliance News) - Yourgene Health PLC on Tuesday said it will sell its subsidiary Yourgene Health Taiwan Co Ltd to INEX Innovate Pte Ltd for up to USD4 million

Read more
22 May 2023 14:26

Yourgene to process tests at lab as part of MyHealthChecked Boots deal

(Alliance News) - Yourgene Health PLC on Monday said that is due to process diagnostic tests at its laboratory in Manchester, as part of a deal signed by its partner, MyHealthChecked PLC, with Boots UK Ltd.

Read more
27 Apr 2023 17:35

TRADING UPDATES: Yourgene Health sees revenue above market forecasts

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.